JUN 15, 2016 12:14 PM PDT

Liposome capsules improve phage therapy

WRITTEN BY: Kerry Evans
Researchers devised a method to improve oral bacteriophage therapy.

The group, made up of investigators from the Autonomous University of Barcelona and the Catalan Institute for Nanoscience and Nanotechnology, encapsulated bacteriophages within liposomes. The liposomes make the phages more resistant to stomach acid and increase the amount of time they spend in the intestinal tract.
 
Bacteriophages (red) target and kill bacteria (blue).

These researchers already demonstrated that oral phage therapy is effective against Salmonella infection in chickens. However, they needed some way to keep the phages from being destroyed by the chicken’s stomach acid and to increase retention time in the intestines.

Enter liposome nanoencapsulation. The capsules have an average diameter of 320 nm and are positively charged. Conveniently, this technique can also be applied to bacteriophages of any shape and size.

The group first showed that encapsulation could protect the phages from stomach acid. When exposed to simulated gastric fluid with a pH of 2.8, the number of “viable” nonencapsulated phages decreased by as much as 7.8 log units. However, the number of encapsulated phages only decreased by around 5.4 log units.

Next, they tested whether encapsulation increased the retention time of phages in the intestinal tract. Sure enough, 38.1% of chickens retained the encapsulated phages in their ceca after 72 hours compared to only 9.5% of chickens that were given nonencapsulated phages.

Finally, they needed to know whether the encapsulated phages could effectively kill Salmonella in the chickens. They tested this by infecting broiler chickens with Salmonella and treating them orally with nonencapsulated or encapsulated phages. Both nonencapsulated and encapsulated phages decreased the Salmonella concentration in the cecum within the first 6 days after infection. However, from days 8 to 15, the encapsulated phages decreased the Salmonella concentration to a much greater degree than the nonencapsulated phages.

Does this mean phage therapy is one step closer to becoming a mainstream antibacterial therapy? Guess we’ll wait and see.

Sources: Applied and Environmental Microbiology, AlphaGalileo
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
JUL 16, 2018
Microbiology
JUL 16, 2018
Cyclospora to Blame for Several Foodborne Outbreaks
One outbreak of cyclosporiasis, which is caused by a parasite, has been traced back to salads sold at McDonald's, mostly in the Midwest....
AUG 10, 2018
Videos
AUG 10, 2018
Can the Black Death Make a Comeback?
The bacterium that causes plague was never wiped out....
AUG 11, 2018
Microbiology
AUG 11, 2018
A Microbrewery can Help us Monitor Radiation Exposure
This wearable technology is very sensitive, and can be used by workers that are at risk of radiation exposure....
AUG 13, 2018
Genetics & Genomics
AUG 13, 2018
A Kind of Forensics to ID the Source of Bacterial Outbreaks
Scientists at Mayo Clinic have developed a way to use whole genome sequencing to locate the source of deadly bacterial pathogens....
AUG 29, 2018
Microbiology
AUG 29, 2018
Finding a New Way to Combat Viruses
A leading cause of birth defects and complication of transplants is the human cytomegalovirus, which can evade our immune system defenses....
OCT 12, 2018
Videos
OCT 12, 2018
Don't Mess With Microbes
Researchers demonstrate why antibiotics should not be used casually....
Loading Comments...